Volume 18 - Issue 3 - March, 2006
Case Report
08/01/2008
Vito Paolillo, MD; Innocenzo Scrocca, MD; Stefania Luceri, MD; Mauro De Benedictis, MD
Spontaneous coronary artery dissection (SCAD) is a rare cause of acute myocardial infarction and sudden death. It typically occurs in healthy women during the peripartum period or in the presence of connective tissue disorders.1–4 Although...
Spontaneous coronary artery dissection (SCAD) is a rare cause of acute myocardial infarction and sudden death. It typically occurs in healthy women during the peripartum period or in the presence of connective tissue disorders.1–4 Although...
Spontaneous coronary artery...
08/01/2008
Journal of Invasive Cardiology
08/01/2008
Ioannis Iakovou, MD; Victor Lim, MD; Lutz Buellesfeld, MD; Gabor Sütsch, MD; Giancarlo Vitrella, MD; Eberhard Grube, MD; Antonio Colombo, MD
Percutaneous coronary intervention (PCI) of a chronic total occlusion (CTO) remains one of the more difficult technical challenges for interventional cardiologists, despite the progress made in the field of PCI in the past decade. CTOs (found...
Percutaneous coronary intervention (PCI) of a chronic total occlusion (CTO) remains one of the more difficult technical challenges for interventional cardiologists, despite the progress made in the field of PCI in the past decade. CTOs (found...
Percutaneous coronary...
08/01/2008
Journal of Invasive Cardiology
08/01/2008
Reynolds Delgado, MD; Biswajit Kar, MD; Matthew D. Forrester, BS, MD; Courtney Gemmato, BS ; Andrew Civitello, MD; Pranav Loyalka, MD; Timothy Myers, BS
Although coronary artery bypass grafting (CABG) is the preferred treatment for disease in an unprotected left main coronary artery or left main equivalent, patients with serious comorbid conditions may be unsuitable for surgical intervention....
Although coronary artery bypass grafting (CABG) is the preferred treatment for disease in an unprotected left main coronary artery or left main equivalent, patients with serious comorbid conditions may be unsuitable for surgical intervention....
Although coronary artery bypass...
08/01/2008
Journal of Invasive Cardiology
08/01/2008
Arun Natarajan, MD; Azfar G. Zaman, BSc, MD, FRCP, MBChB; Scott Gall, MBBS, MRCP, MD; Aamir Tarique, MD
Individual protocols for mobilization after diagnostic cardiac catheterization differ widely between units. Prolonged bed rest increases patient discomfort, limits total numbers of procedures and increases healthcare costs. The current trend...
Individual protocols for mobilization after diagnostic cardiac catheterization differ widely between units. Prolonged bed rest increases patient discomfort, limits total numbers of procedures and increases healthcare costs. The current trend...
Individual protocols for...
08/01/2008
Journal of Invasive Cardiology
Commentary
08/01/2008
William S. Weintraub, MD, FACC; James Hopkins, MD
In this issue of the Journal, Biswajit Kar, et al. report their initial experience using the TandemHeart Percutaneous Ventricular Assist Device (CardiacAssist, Inc., Pittsburgh, Pennsylvania) in patients who were undergoing a high-risk...
In this issue of the Journal, Biswajit Kar, et al. report their initial experience using the TandemHeart Percutaneous Ventricular Assist Device (CardiacAssist, Inc., Pittsburgh, Pennsylvania) in patients who were undergoing a high-risk...
In this issue of the Journal,...
08/01/2008
Journal of Invasive Cardiology
Commentary
08/01/2008
Adnan K. Chhatriwalla, MD; Deepak L. Bhatt, MD, MPH, FACC, FAHA, FESC, MSCAI
There has been an impressive decrease in the incidence of vascular complications following cardiac catheterization in recent years;1 however, excess bleeding from the access site, hematoma, arteriovenous fistula and arterial pseudoaneurysm...
There has been an impressive decrease in the incidence of vascular complications following cardiac catheterization in recent years;1 however, excess bleeding from the access site, hematoma, arteriovenous fistula and arterial pseudoaneurysm...
There has been an impressive...
08/01/2008
Journal of Invasive Cardiology
Case Report
08/01/2008
Alejandro R. Peirone, MD; Ana Spillman, MD; Carlos A.C. Pedra, MD
Pulmonary arteriovenous fistulae, or malformations (PAVMs), are congenital or (rarely) acquired abnormal vascular connections between a pulmonary artery and a pulmonary vein. The fistula itself is typically a thin-walled aneurysmal vascular...
Pulmonary arteriovenous fistulae, or malformations (PAVMs), are congenital or (rarely) acquired abnormal vascular connections between a pulmonary artery and a pulmonary vein. The fistula itself is typically a thin-walled aneurysmal vascular...
Pulmonary arteriovenous...
08/01/2008
Journal of Invasive Cardiology
08/01/2008
Salman Ashfaq, MD; Ziyad Ghazzal, MD; Douglas C. Morris, MD; Emir Veledar, MD; William S. Weintraub, MD, FACC; John S. Douglas, Jr., MD
While an increasing proportion of the grafts used during coronary artery bypass (CABG) procedures are arterial, the majority of grafts implanted at most centers have been and continue to be saphenous vein grafts. On long-term follow up, up to...
While an increasing proportion of the grafts used during coronary artery bypass (CABG) procedures are arterial, the majority of grafts implanted at most centers have been and continue to be saphenous vein grafts. On long-term follow up, up to...
While an increasing proportion...
08/01/2008
Journal of Invasive Cardiology
IAGS (International Andreas Gruentzig Society) Proceedings
08/01/2008
Kirk N. Garrett; Alex Martin; Marcia Schallehn; Matthew Jenusaitis; Matthew Pollman; Brian Firth, MD, PhD, MBA; Jamey Jacobs
Brian Firth (Cordis Corporation): As you all probably know, Cordis, in its entirety, is a cardiovascular device company, and now a combination drug/device company. There are four major divisions: 1) Cordis Cardiology, 2) Cordis Endovascular,...
Brian Firth (Cordis Corporation): As you all probably know, Cordis, in its entirety, is a cardiovascular device company, and now a combination drug/device company. There are four major divisions: 1) Cordis Cardiology, 2) Cordis Endovascular,...
Brian Firth (Cordis...
08/01/2008
Journal of Invasive Cardiology
08/01/2008
Yoriyasu Suzuki, MD; Alan C. Yeung, MD; Fumiaki Ikeno, MD
Recent studies have shown that the use of drug-eluting stents (DES) to deliver antiproliferative agents directly to the vessel wall dramatically reduces the rate of restenosis. However, differences among stent designs, drug delivery vehicles,...
Recent studies have shown that the use of drug-eluting stents (DES) to deliver antiproliferative agents directly to the vessel wall dramatically reduces the rate of restenosis. However, differences among stent designs, drug delivery vehicles,...
Recent studies have shown that...
08/01/2008
Journal of Invasive Cardiology
